Kicking off a holiday-shortened week for the markets, Jim Cramer and David Faber highlighted the latest vaccine news to lift stocks: AstraZeneca announced that its COVID-19 vaccine being developed in conjunction with Oxford University was up to 90 percent effective with no serious side effects in a clinical trial. The anchors explored the push to develop and ... Show More
Nov 21
Squawk on the Street+ Liberty Media Chairman John Malone 11/21/25
<p>Liberty Media Chairman John Malone sits down with CNBC’s David Faber before he steps down as chairman on January 1, 2026. In this wide ranging conversation, Malone discusses his career as detailed in his memoir, <i>Born to Be Wired: Lessons from a Lifetime Transforming Televis ... Show More
59m 6s
Nov 21
SOTS 2nd Hour: Volatility Picks, Navigating Big Tech, & The Bitcoin Breakdown 11/21/25
<p>Stocks on pace for their worst month since March after Nvidia's turn lower yesterday hit the AI trade:</p><p>Carl Quintanilla, Leslie Picker, and David Faber kicked off the hour with fresh consumer data before breaking down the broader market picture with Cantor Fitzgerald's C ... Show More
43m 31s
Jan 2025
AI, vaccine distrust, and the future of healthcare: Novartis CEO
Can science prevail against this more turbulent backdrop of the Trump administration? Yahoo Finance executive editor Brian Sozzi talks at length with Novartis CEO Vas Narasimhan. Narasimhan has led the drug giant since 2018, doing deals that have expanded the company’s pipeline i ... Show More
25m 45s
Oct 18
What’s News in Markets: AI Deals, Trump on Pharma, Banks Split
How did the week’s AI dealmaking affect stocks? And why did President Trump’s comments on weight-loss drugs hurt pharma shares? Plus, how did the big six U.S. banks finish out the week after strong quarterly reports? Host Francesca Fontana discusses the biggest stock moves of the ... Show More
6m 19s